David Cosgrove

Oncology

210 SE 136th Ave
Vancouver, WA 98684

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

ER degradation for ER+/HER2- advanced or metastatic breast cancer: a phase 1 trial.

ER degradation for ER+/HER2- advanced or metastatic breast cancer: a phase 1 trial.

Journal: Nature communications

Published: August 19, 2025

Biomarker testing, treatment patterns and outcomes in previously treated pMMR or non-MSI-H metastatic colorectal cancer patients.

Biomarker testing, treatment patterns and outcomes in previously treated pMMR or non-MSI-H metastatic colorectal cancer patients.

Journal: Future oncology (London, England)

Published: May 15, 2025

Real-world treatment patterns and outcomes among patients initiating sequential regorafenib and trifluridine/tipiracil ± bevacizumab in patients with metastatic colorectal cancer in a US community setting (SEQRT2).

Real-world treatment patterns and outcomes among patients initiating sequential regorafenib and trifluridine/tipiracil ± bevacizumab in patients with metastatic colorectal cancer in a US community setting (SEQRT2).

Journal: Frontiers in oncology

Published: March 10, 2025

Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network.

Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network.

Journal: Journal of hepatocellular carcinoma

Published: October 08, 2024

A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer.

A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer.

Journal: Journal of hepatology

Published: July 26, 2024

COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC.

COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC.

Journal: Future oncology (London, England)

Published: June 11, 2024

Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study.

Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study.

Journal: EClinicalMedicine

Published: October 17, 2022

Real-world outcomes among patients with advanced or metastatic biliary tract cancers initiating second-line treatment.

Real-world outcomes among patients with advanced or metastatic biliary tract cancers initiating second-line treatment.

Journal: Cancer medicine

Published: March 30, 2022

Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.

Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: May 19, 2021

NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121).

NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121).

Journal: Future oncology (London, England)

Published: May 07, 2020

Comparison of liver stiffness measurements by a 2D-shear wave technique and transient elastography: results from a European prospective multi-centre study.

Comparison of liver stiffness measurements by a 2D-shear wave technique and transient elastography: results from a European prospective multi-centre study.

Journal: European radiology

Published: April 24, 2020

TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial.

TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial.

Journal: JMIR research protocols

Published: October 12, 2018

Showing 1-12 of 84

Last Updated: 09/26/2026